Phosphate momentum tested by regulatory headwinds
Q1's 36% revenue surge puts Paradeep in strong form heading into Q2 results on Oct 29. Street expects the run to continue, but watch for margin resilience amid a ₹93.59 Cr customs penalty and the capex roadmap for its ₹4,750 Cr Odisha expansion.
Paradeep Phosphates enters Q2 FY27 on the back of a strong Q1, reporting 36% YoY revenue growth to ₹6,124 Cr and 24% EBITDA expansion to ₹764 Cr. The phosphate and fertilizer cycle has been robust—global prices have moderated from mid-2026 highs, but domestic demand remains steady. With the Street holding a BUY consensus and the stock at ₹138.97 vs. an average analyst target of ₹197.33, the market has embedded optimism about execution. The Q2 print will test two things: whether the margin momentum seen in Q1 (EBITDA margin ~12.5%) holds as input costs stabilise, and how the company frames its capex roadmap in light of the ₹4,750 Cr Odisha expansion MoU signed on Oct 23.
What to expect
~₹6,100–6,300 Cr
Q1 delivered ₹6,124 Cr with 36% YoY growth; Q2 FY26 base was ₹6,872 Cr. Expect near-flat to modest QoQ given seasonal phosphate flows.
~₹750–800 Cr
Q1 EBITDA margin ~12.5% (₹764 Cr). Assume similar 12.2–12.7% on Q2 revenue, barring input cost shocks.
~₹380–420 Cr
Q1 PAT ₹393 Cr. Watch for impact of the ₹93.59 Cr customs penalty (Aug 21); if taken in Q2, it will suppress the print vs. standalone guidance.
EBITDA margin ~12–13%
Input costs (phosphoric acid, ammonia, raw materials) and input duty changes are the swing factors. Q1 benefited from stable input costs post-summer; Q2 will show whether that holds.
A strong Q2 print would show: revenue momentum sustained (₹6,100+ Cr), EBITDA margin above 12.5%, and clarity that the customs penalty is resolved with minimal ongoing impact. A weak print would show: revenue dips below ₹6,000 Cr (demand slowdown), EBITDA margin compresses below 12% (input cost inflation), or a significant one-time charge related to the customs penalty that wasn't already provided for in Q1.
On track?
Paradeep has not issued explicit FY27 guidance, but the Q1 trajectory (36% revenue growth, 24% PBT growth YoY) suggests management sees strong underlying demand. For H1 to stay on track, Q2 must deliver mid-to-high single-digit QoQ revenue growth and sustain margin expansion. The customs fine (₹93.59 Cr, issued Aug 21, related to urea import mis-declaration in prior years) is a known headwind; clarity on whether it's been accrued, and whether any appeal is pending, will matter for full-year profit guidance. The ₹4,750 Cr Odisha MoU and ₹250 Cr AlF₃ plant expansion signal confidence in long-term capacity, but capex intensity in FY27–28 will be a key watch.
What the Street says
Since last quarter: key filings & events
Oct 26, 2026
Board meeting intimation for Q2 results (Oct 29, 2026)
Routine
Oct 23, 2026
Odisha MoU: ₹4,750 Cr investment in chemical & fertilizer facilities
Positive growth signal; capex roadmap to clarify
Oct 13, 2026
Board appoints Raj Kumar Agrawal as Independent Director
Routine governance
Aug 25, 2026
FY26 BRSR (ESG report) filed; AGM scheduled Sep 17, 2026
Routine disclosures
Aug 22, 2026
Promoter (Zuari Maroc) releases 4 Cr encumbered shares
Pledge clarity; 57.86% promoter stake intact
Aug 21, 2026
Customs fine ₹93.59 Cr for urea mis-declaration (prior years' imports)
Headwind; accrual impact on Q2 profits unclear
Aug 8, 2026
Supreme Court wins appeal; ₹53.50 Cr fertilizer subsidy released
Positive one-time; improves H1 FY27 cash
Jul 28, 2026
Q1 results announced; ₹250 Cr AlF₃ plant capex approved
Strong revenue, margin, and growth signal
Ownership trends: FII holding has declined from 8.36% (Q4 FY26) to 5.10% (Q1 FY27), a -326 bp outflow, while DII has increased from 15.49% to 18.08%, a +259 bp inflow. Promoters (Zuari Maroc) remain steady at 57.86%, with all pledges cleared as of Aug 22. The FII rotation away suggests some defensiveness on near-term valuation, even as domestic flows remain constructive.
Three things to watch on result day
1 · Margin resilience amid input cost shifts
With commodity phosphate and ammonia prices now more benign vs. Q1, can Paradeep protect EBITDA margin above 12%? If it dips to 11% or below, it suggests either input cost inflation or pricing pressure—both red flags for the bulls.
2 · Customs fine treatment and FY27 guidance
Clarity on whether the ₹93.59 Cr penalty is fully accrued in Q2, or if it's a contingent liability with appeal pending. Any material provision surprise will reshape profit expectations. Management should also clarify FY27 guidance: is 25–30% full-year growth on the table, or has the easy comp lap passed?
3 · Capex phasing for Odisha & AlF₃ plants; FY27–28 ROE outlook
The ₹4,750 Cr Odisha MoU and ₹250 Cr AlF₃ plant represent a significant capex cycle. Investors want clarity on phasing, funding mix (debt vs. equity), and expected payoff timeline. A vague roadmap or high leverage assumption could weigh on the stock despite strong near-term profit growth.
Paradeep Phosphates is set to report Q2 FY27 results on Oct 29 with momentum on its side: Q1 saw 36% revenue growth and strong margin expansion, the fertilizer cycle is stable, and the Street's BUY consensus reflects confidence in execution. But three forces will determine whether the beat extends: (1) EBITDA margin sustenance as input costs normalise, (2) clear resolution of the ₹93.59 Cr customs penalty overhang, and (3) a credible capex roadmap and ROE outlook for the ₹4,750 Cr Odisha expansion. FII outflow and a stock trading 30% below recent highs suggest valuation has priced in risk; a weak print or vague guidance on capex funding could test support, while a strong beat with clear FY27–28 growth visibility could re-engage institutional demand.